- Peripheral blood and bone marrow tests showed normal results with no abnormalities.
- Cerebrospinal fluid (CSF) cytology was negative for malignant cells.
- Serum tests showed positive results for Toxoplasma IgG and negative for Toxoplasma IgM, consistent with a chronic or past infection.
- The clinical presentation, lab results, and lack of abnormal findings on other tests results in a diagnosis of toxoplasmosis.
- Peripheral blood and bone marrow tests showed normal results with no abnormalities.
- Cerebrospinal fluid (CSF) cytology was negative for malignant cells.
- Serum tests showed positive results for Toxoplasma IgG and negative for Toxoplasma IgM, consistent with a chronic or past infection.
- The clinical presentation, lab results, and lack of abnormal findings on other tests results in a diagnosis of toxoplasmosis.
- Peripheral blood and bone marrow tests showed normal results with no abnormalities.
- Cerebrospinal fluid (CSF) cytology was negative for malignant cells.
- Serum tests showed positive results for Toxoplasma IgG and negative for Toxoplasma IgM, consistent with a chronic or past infection.
- The clinical presentation, lab results, and lack of abnormal findings on other tests results in a diagnosis of toxoplasmosis.
- Normocellular bone marrow with normal trilineage hematopoiesis.
Diagnosis: CSF, cytology:
Negative for malignant cells.
Serum labartories : • Toxo IG M 0.12
• Anti Toxoplasma Ab-IgG 27.1 +ve
• Clinical Symptoms • The clinical manifestations of toxoplasmosis vary greatly, producing a range of nonspecific symptoms. In immunocompetent patients, infection is usually asymptomatic or very mild. Common symptoms include cervical lymphadenopathy and other symptoms of generalized infection. These include fever, malaise, night sweats, myalgia, sore throat and maculopapular rash. • The clinical course in immunocompromised patients can be much more severe. These infections usually stem from reactivated latent infection, rather than newly acquired infection. Important symptoms include encephalitis, myocarditis and pneumonitis, with death being almost certain if the disease is left untreated. In AIDS patients, toxoplasma encephalitis is especially frequent, occurring in 10-50% of seropositive patients with CD4 T-cell counts less than 100/μL. • Toxoplasmosis in congenitally infected newborns can present in a nonspecific manner with a wide range of symptoms, some of which can also be quite severe. These include chorioretinitis, blindness, epilepsy, mental retardation, anemia, jaundice, encephalitis, pneumonitis and others. Complete recovery is very rare. • https://web.stanford.edu/group/parasites/ParaSites2006/Toxoplasmosis/symp toms.html • Diagnosis • The diagnosis of toxoplasmosis can be done using a variety of methods. The difficulty lies in determining whether the infection is acute or chronic. Acute infection can best be verified by isolating T. gondii or T. gondii DNA from the patient's blood or finding tachyzoites in tissue or bodily fluids. Congenital infection of fetuses can be identified by the presence of cysts in the placenta or fetus. • The isolation of T. gondii tissue cysts is not sufficient to determine whether the infection is still active or has entered the latent phase. To differentiate the two, patients are subjected to several serological exams, the specific combination of which depends on clinical category of the patient. These exams include the Sabin-Feldman dye test, which tests for IgG antibodies; ELISAs targeted at IgM, IgA and IgE; differential agglutination tests and IgG avidity tests. • Of particular interest is determining acute infection in pregnant women, due to the risk of congenital toxoplasmosis. This is complicated by the fact that many women have existing IgG and IgM antibodies to T. gondii from infection in the past. There are effective diagnostic techniques that monitor changes in the mother's antibody expression over time, but quick diagnosis is greatly preferred because fetuses often rapidly become infected. • Treatment • Treatment of toxoplasmosis in immunocompetent patients is usually unnecessary. In immunocompromised patients, the recommended treatment is a combination of pyrimethamine given at 25-100 mg daily and trisulfapyrimidines given at 2-6 g daily, both for a month. This drug combination inhibits dihydrofolate reductase in T. gondii, preventing synthesis of DNA and protein. Folinic acid can also be administered to reduce bone marrow depression caused by the pyrimethamine. Clindamycin has been found to be effective at treating toxoplasma encephalitis in AIDS patients. • Prevention • Prevention of primary infection is currently best achieved through health education. Recommendations include adequately cooking meat before consumption at temperatures of at least 150 degrees F and avoiding handling raw meat with ungloved hands. Cat owners are warned to avoid directly handling litter trays or soil that may be contaminated with cat feces. Cats that are fed commercial cat food are less likely to get infected than cats that hunt. Pregnant women especially should avoid contact with cats or handling litter trays. • There are no vaccines currently available for T. gondii, although several are in early in development. Prevention of congenital transmission is possible through early diagnosis of acute infection in mothers and administration of a prophylactic regimen of spiramycin. Informational Links DPDx website. Description of T. gondii biology, epidemiology and clinical aspects. http://www.dpd.cdc.gov/dpdx/HTML/Toxoplasmosis.htm CDC fact sheet. Public health information and recommendations. http://www.cdc.gov/ncidod/dpd/parasites/toxoplasmosis/factsht_to xoplasmosis.htm ToxoDB website. Contains unfinished genomic sequence of T. gondii. http://www.toxodb.org/ToxoDB.shtml The New Mexico AIDS InfoNet. Information about toxoplasmosis directed at AIDS patients. http://www.aidsinfonet.org/factsheet_detail.php?fsnumber=517 Toxoplasmosis: An Important Message for Women. Fact sheet put out by the CDC. http://www.cdc.gov/ncidod/dpd/parasites/toxoplasmosis/ToxoWom en.pdf Last Update: 24 May 2006
A Toxoplasma-positive reaction, stained by immunofluroescence (IFA). • life Cycle: • • • The only known definitive hosts for Toxoplasma gondii are members of family Felidae (domestic cats and their relatives). Unsporulated oocysts are shed in the cat’s feces . Although oocysts are usually only shed for 1-3 weeks, large numbers may be shed. Oocysts take 1-5 days to sporulate in the environment and become infective. Intermediate hosts in nature (including birds and rodents) become infected after ingesting soil, water or plant material contaminated with oocysts . Oocysts transform into tachyzoites shortly after ingestion. These tachyzoites localize in neural and muscle tissue and develop into tissue cyst bradyzoites . Cats become infected after consuming intermediate hosts harboring tissue cysts . Cats may also become infected directly by ingestion of sporulated oocysts. Animals bred for human consumption and wild game may also become infected with tissue cysts after ingestion of sporulated oocysts in the environment . Humans can become infected by any of several routes:Eating undercooked meat of animals harboring tissue cysts . • Consuming food or water contaminated with cat feces or by contaminated environmental samples (such as fecal- contaminated soil or changing the litter box of a pet cat) . • Blood transfusion or organ transplantation . • Transplacentally from mother to fetus . • In the human host, the parasites form tissue cysts, most commonly in skeletal muscle, myocardium, brain, and eyes; these cysts may remain throughout the life of the host. Diagnosis is usually achieved by serology, although tissue cysts may be observed in stained biopsy specimens . Diagnosis of congenital infections can be achieved by detecting T. gondii DNA in amniotic fluid using molecular methods such as PCR • Healthy people (nonpregnant) • Healthy people who become infected with Toxoplasma gondii often do not have symptoms because their immune system usually keeps the parasite from causing illness. When illness occurs, it is usually mild with “flu- like” symptoms (e.g., tender lymph nodes, muscle aches, etc.) that last for weeks to months and then go away. However, the parasite remains in the person’s body in an inactive state. It can become reactivated if the person becomes immunosuppressed. • Diagnosis • • A Toxoplasma-positive reaction, stained by immunofluroescence (IFA). (CDC Photo) • The diagnosis of toxoplasmosis is typically made by serologic testing. A test that measures immunoglobulin G (IgG) is used to determine if a person has been infected. If it is necessary to try to estimate the time of infection, which is of particular importance for pregnant women, a test which measures immunoglobulin M (IgM) is also used along with other tests such as an avidity test. • Diagnosis can also be made by direct observation of the parasite in stained tissue sections, cerebrospinal fluid (CSF), or other biopsy material. These techniques are used less frequently because of the difficulty of obtaining these specimens. • Parasites can also be isolated from blood or other body fluids (for example, CSF) but this process can be difficult and requires considerable time. • Molecular techniques that can detect the parasite’s DNA in the amniotic fluid can be useful in cases of possible mother-to-child (congenital) transmission. • Ocular disease is diagnosed based on the appearance of the lesions in the eye, symptoms, course of disease, and often serologic testing. • The common presenting symptom of cerebral toxoplasmosis is headache, often accompanied by fever and altered mental status (9). Individuals may also present with visual disturbances, seizures, cranial nerve abnormalities, and sensory disturbances. The common neurological signs include motor weakness and speech disturbances (7). • The most common affected areas in CNS include the basal ganglia, corticomedullary junction, white matter, and periventricular regions. • This showed radiating enhancement in cortical/subcortical regions having very few nodular or ring-enhancing lesions—quite different from those in the immunocompromised patients • ike toxoplasmosis, CNS lymphoma also has a predilection for the basal ganglia. Unifocal and multifocal involvements are observed in both conditions. Both have varied patterns of enhancement, edema, and mass effect on CT images, and increased signal intensity on T2- weighted MR images. Lesions in lymphoma are usually more locally infiltrative; hence, a butterfly-like pattern of spread and enhancement favors lymphoma more than toxoplasmosis. In addition to this, lymphomatous lesions are usually larger than those of toxoplasmosis (15) and tend to have a periventricular distribution • The other differential diagnoses for multiple intraparenchymal brain lesions include tuberculoma, aspergillosis, progressive multifocal leukoencephalopathy, bacterial abscess, and cryptococcosis • In our case, with the multiplicity of lesions and onset of newer lesions within a span of one week, showing a mixed, nodular enhancement pattern and raised lipid lactate peak on MR spectroscopy, a diagnosis of CNS toxopl • https://www.ncbi.nlm.nih.gov/pmc/articles/P MC4838758/ asmosis was made • CNS Toxoplasmosis • One of the most common opportunistic infections in the AIDS population caused by the obligate intracellular protozoan Toxoplasma gondii. • Almost always caused by reactivation of a chronic infection, and usually becomes symptomatic when the CD4 count becomes < 100 μL. • Clinical features: Subacute onset with focal neurologic abnormalities accompanied by headache, change in mental status and fever. • Key Diagnostic Features: Favored locations: Basal ganglia and corticomedullary junction. CT: Iso- to hypodense lesions demonstrating peripheral enhancement. MR: Heterogenous mass lesion. Typically, central necrosis does not demonstrate restricted diffusion. Hemorrhage may be seen. MR spectroscopy demonstrates reduction in NAA/Cr with presence of lipid and lactate. Occasionally, an elevated Cho peak may be seen. • DDx: Lymphoma, TB, primary brain tumor, metastatic brain tumor, tumefactive demyelinating lesion. • Rx: Antitoxoplasmosis treatment Similar case • https://www.ncbi.nlm.nih.gov/pmc/articles/P MC6290221/ • The incidence of primary toxoplasmosis in immunocompetent individuals in French Guiana, according to a study done by Carme et al, is very minimal, about 0.018% (4). However, at present, no data is available for the Indian population.
The Perfect Neutropenic Diet Cookbook; The Complete Nutrition Guide To Reinstating Overall Health For General Wellness With Delectable And Nourishing Recipes